Oncolytics Biotech Correlations

ONCY Stock  USD 0.79  0.05  5.95%   
The current 90-days correlation between Oncolytics Biotech and Milestone Pharmaceuticals is -0.02 (i.e., Good diversification). The correlation of Oncolytics Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Oncolytics Biotech Correlation With Market

Average diversification

The correlation between Oncolytics Biotech and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Oncolytics Stock please use our How to Invest in Oncolytics Biotech guide.

Moving together with Oncolytics Stock

  0.78EQ EquilliumPairCorr
  0.79ME 23Andme HoldingPairCorr
  0.92VALN Valneva SE ADRPairCorr
  0.68DNLI Denali TherapeuticsPairCorr
  0.74DNTH Dianthus TherapeuticsPairCorr
  0.63DOMH Dominari HoldingsPairCorr
  0.91DRRX DurectPairCorr
  0.84DTIL Precision BioSciencesPairCorr
  0.88VIGL Vigil NeurosciencePairCorr
  0.91VINC Vincerx PharmaPairCorr
  0.85VKTX Viking TherapeuticsPairCorr
  0.77VRCA Verrica PharmaceuticalsPairCorr
  0.84VRDN Viridian Therapeutics Buyout TrendPairCorr
  0.8VRPX Virpax PharmaceuticalsPairCorr

Moving against Oncolytics Stock

  0.89VCEL Vericel Corp OrdPairCorr
  0.88VCYT Veracyte Potential GrowthPairCorr
  0.81DRTS Alpha Tau MedicalPairCorr
  0.73DMAC DiaMedica TherapeuticsPairCorr
  0.61CDIOW Cardio DiagnosticsPairCorr
  0.53SABSW SAB BiotherapeuticsPairCorr
  0.76DYAI Dyadic InternationalPairCorr
  0.74DVAX Dynavax TechnologiesPairCorr
  0.71VRNA Verona Pharma PLCPairCorr
  0.69VSTM VerastemPairCorr
  0.61SRZNW Surrozen WarrantPairCorr
  0.47KTTAW Pasithea TherapeuticsPairCorr
  0.45VTRS ViatrisPairCorr
  0.34VTVT vTv TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
TERNSCPH
IKTDMAC
DMACMCRB
DMACMIST
XFORIKT
IKTMIST
  
High negative correlations   
MISTSCPH
TERNMIST
DMACSCPH
TERNDMAC
IKTSCPH
GRTXXFOR

Risk-Adjusted Indicators

There is a big difference between Oncolytics Stock performing well and Oncolytics Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncolytics Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Oncolytics Biotech Corporate Management

Amy LevinVice OperationsProfile
FCA FCAConsultantProfile
Jon PattonDirector CommunicationProfile
FACP FACPConsultantProfile
Wayne MBAInterim BoardProfile
Andrew GuttadauroGlobal IncProfile